tiprankstipranks
Verve Therapeutics (VERV)
NASDAQ:VERV
US Market

Verve Therapeutics (VERV) Financial Statements

363 Followers

Verve Therapeutics Financial Overview

Verve Therapeutics's market cap is currently ―. The company's EPS TTM is $-3.13; its P/E ratio is -4.41; Verve Therapeutics is scheduled to report earnings on May 7, 2024, and the estimated EPS forecast is $-0.73. See an overview of income statement, balance sheet, and cash flow financials.
Sep 23Jun 23Mar 23Dec 22Sep 22
Income Statement-
Total Revenue----$ 929.00K
Gross Profit-----
EBIT$ -45.69M$ -53.81M$ -51.98M$ -43.21M$ -43.86M
EBITDA$ -47.71M$ -56.17M$ -54.70M$ -44.42M$ -43.14M
Net Income Common Stockholders$ -45.79M$ -53.98M$ -51.98M$ -41.09M$ -45.19M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 485.23M$ 462.48M$ 508.69M$ 554.81M$ 550.71M
Total Assets$ 612.41M$ 589.13M$ 634.38M$ 660.45M$ 673.36M
Total Debt$ 76.81M$ 77.86M$ 80.11M$ 81.92M$ 79.92M
Net Debt$ -408.42M$ -384.61M$ -428.58M$ -472.89M$ -470.80M
Total Liabilities$ 152.04M$ 123.91M$ 124.90M$ 128.29M$ 125.41M
Stockholders Equity$ 460.37M$ 465.22M$ 509.48M$ 550.93M$ 547.94M
Cash Flow-
Free Cash Flow$ -12.87M$ -50.62M$ -52.47M$ -36.79M$ -31.81M
Operating Cash Flow$ -11.81M$ -47.96M$ -49.10M$ -31.82M$ -29.18M
Investing Cash Flow$ -11.83M$ 33.02M$ 15.39M$ -168.31M$ -55.52M
Financing Cash Flow$ 31.92M$ 1.23M$ 2.04M$ 38.53M$ 288.41M
Currency in USD

Verve Therapeutics Earnings and Revenue History

Verve Therapeutics Debt to Assets

Verve Therapeutics Cash Flow

Verve Therapeutics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis